Skip to main content Skip to main navigation menu Skip to site footer
logo Mediterranean Journal of Hematology and Infectious Diseases

eISSN 2035-3006

  • Home
  • About the Journal
  • Editorial Board
  • Current
  • Archives
  • Announcements
  • Register
  • Login
  • Journal Statistics
  • Search
  • Contact
  • Announcements

Editor-in-Chief: Giuseppe Leone | Italy

2.3
Impact Factor 2025
3.2
CiteScore 2025
2.3
Impact Factor 2025
3.2
CiteScore 2025
Submit
an article
  1. Home /
  2. Search

Search

Advanced filters
Published After
Published Before

Search Results

##search.searchResults.foundPlural##
  • SAFETY OF BRONCHOALVEOLAR LAVAGE IN HEMATOLOGICAL PATIENTS WITH THROMBOCYTOPENIA – A RETROSPECTIVE COHORT STUDY

    Ivan GUR, Roei Tounek, Yaniv Dotan, Elite Vainer Evgrafov, Stav Rakedzon, Eyal Fuchs
    e2024006
    2024-01-01
    https://doi.org/10.4084/MJHID.2024.006
    1208
    PDF: 1305
    HTML: 205
  • AN OBSERVATIONAL STUDY OF THE EFFECT OF HEMOGLOBINOPATHY, ALPHA THALASSEMIA AND HEMOGLOBIN E ON P. VIVAX PARASITEMIA

    Suparak Para, Puncharee Mungkalasut, Makamas Chanda, Issarang Nuchprayoon, Srivicha Krundsood, Chalisa Louicharoen Cheepsunthorn
    e2018015
    2018-02-16
    https://doi.org/10.4084/mjhid.2018.015
    2841
    PDF: 910
    HTML: 381
    Distribution of malaria patient cohort along Thailand and borders during 2011-2012: 201
  • VCAM-1 and ICAM-1 serum levels as markers of relapse in visceral leishmaniasis

    Alexandros Makis, Sophia Tsabouri, Paraskevi Karagouni, Maria Rogalidou, Irene Sionti, Nikolaos Chaliasos
    e2017011
    2017-01-01
    https://doi.org/10.4084/mjhid.2017.011
    2822
    PDF: 800
    HTML: 1531
  • Transfusion associated peak in Hb HPLC chromatogram – a case report

    Sonal Jain, Jasmita Dass, Hara Prasad Pati
    e2012006
    2012-01-21
    https://doi.org/10.4084/mjhid.2012.006
    1090
    PDF: 780
    HTML: 2746
  • THERAPY-RELATED MYELOID MALIGNANCIES IN MYELOMA

    Xenofon Papanikolaou, Bart Barlogie, Saad Usmani
    e2011047
    2011-10-24
    https://doi.org/10.4084/mjhid.2011.047
    2499
    PDF: 797
    HTML: 1738
  • EVOLUTION OF HEMOGLOBINOPATHY PREVENTION IN AFRICA

    Slaheddine Fattoum
    e2009005
    2009-10-27
    1061
    PDF: 429
    HTML: 15035
  • The MINI-POLATUZUMAB VEDOTINE PLUS CHP (POLA-R-CHP) VS. MINI-R-CHOP IN PATIENTS OVER 80 YEARS OF AGE WITH DIFFUSE LARGE B-CELL LYMPHOMA: A RETROSPECTIVE, PROPENSITY SCORE-MATCHED ANALYSIS STRATIFIED BY SIMPLIFIED FRAILTY SCORE PolaRCHP vs. RCHOP for older patients

    Shuku Sato
    e2025070
    2025-10-31
    https://doi.org/10.4084/MJHID.2025.070
    1231
    PDF: 418
    HTML: 98
  • THALIDOMIDE FOR PATIENTS WITH THALASSEMIA INTERMEDIA: A RETROSPECTIVE MULTICENTER CLINICAL STUDY

    Kun Yang, Yi Wu, Yali Zhou, Tianhong Zhou, Li Wang, Zhili Geng, Xiaolin Yin
    e2020021
    2020-04-27
    https://doi.org/10.4084/mjhid.2020.021
    2242
    PDF: 1254
    HTML: 352
  • LONGITUDINAL STUDY ON LIVER FUNCTIONS IN PATIENTS WITH THALASSEMIA MAJOR BEFORE AND AFTER DEFERASIROX (DFX) THERAPY

    Ashraf Tawfik Soliman, Mohamed Yassin, Fawzia AlYafei, Lolwa Al-Naimi, Noora Almarri, Aml Sabt, Vincenzo De Sanctis
    e2014025
    2014-04-06
    https://doi.org/10.4084/mjhid.2014.025
    2282
    PDF: 2168
    HTML: 2438
  • VITAMIN D STATUS IN THALASSEMIA MAJOR: AN UPDATE

    Ashraf Tawfik Soliman
    e2013057
    2013-09-02
    https://doi.org/10.4084/mjhid.2013.057
    2760
    PDF: 1093
    HTML: 2583
  • IMMUNOGLOBULIN GENE REPERTOIRE IN CHRONIC LYMPHOCYTIC LEUKEMIA: INSIGHT INTO ANTIGEN SELECTION AND MICROENVIRONMENTAL INTERACTIONS

    Efterpi Kostareli, Maria Gounari, Andreas Agathangelidis, Kostas Stamatopoulos
    e2012052
    2012-08-09
    https://doi.org/10.4084/mjhid.2012.052
    3099
    PDF: 886
    HTML: 7172
    Kost Fig1: 195
    Kost Fig 2: 187
    Kost Fig3: 186
    Kost Fig 4: 199
    Kost Fig5: 194
    Kost fig 6: 181
  • Guest Editor: Pellegrino Musto HOW FIRST LINE THERAPY IS CHANGING IN TRANSPLANT-ELIGIBLE MULTIPLE MYELOMA PATIENTS

    Yasmine Houbaida, Maria Livia Del Giudice, Sara Galimberti, Gabriele Buda
    e2025026
    2025-02-27
    https://doi.org/10.4084/MJHID.2025.026
    1982
    PDF: 1670
    HTML: 133
  • THE GROWING ROLE OF THE BH3 MIMETIC DRUG VENETOCLAX IN THE THERAPY OF ACUTE MYELOID LEUKEMIA

    Elvira Pelosi, Dr. Germana Castelli, Ugo Testa
    e2022080
    2022-10-29
    https://doi.org/10.4084/MJHID.2022.080
    1535
    PDF: 1174
    HTML: 290
  • SYSTEMIC MASTOCYTOSIS: MOLECULAR LANDSCAPE AND IMPLICATIONS FOR TREATMENT

    Cecilia Monaldi, Sara De Santis, Manuela Mancini, Samantha Bruno, Michele Cavo, Simona Soverini
    e2021046
    2021-06-28
    https://doi.org/10.4084/MJHID.2021.046
    1428
    PDF: 745
    HTML: 308
  • TREATMENT OF EARLY STAGES HODGKIN LYMPHOMA DURING PREGNANCY

    Agustin Avilès, Maria-Jesus Nambo, Natividad Neri
    e2018006
    2018-01-01
    https://doi.org/10.4084/mjhid.2018.006
    3592
    PDF: 1086
    HTML: 880
  • Skin Manifestations associated with Mantle cell Lymphoma: a case report

    avinash kumar singh, Gaurav Dixit, sanjeev sharma, rajni yadav, Narendra agrawaal, chitra sarkar, pravas mishra, Tulika seth, manoranjan mahapatra, Renu saxena
    e2013020
    2013-02-24
    https://doi.org/10.4084/mjhid.2013.020
    1578
    PDF: 772
    HTML: 2153
    Untitled: 228
    Untitled: 200
    Untitled: 197
    Untitled: 208
    Untitled: 202
  • SUSTAINED REMISSION IN AN ELDERLY PATIENT WITH ACUTE MYELOID LEUKEMIA FOLLOWING GILTERITINIB TREATMENT AS THIRD-LINE SALVAGE THERAPY Long-lasting disease remission with third line therapy with gilteritinib

    Matteo Molica
    e2024079
    2024-10-31
    https://doi.org/10.4084/MJHID.2024.079
    961
    PDF: 524
    HTML: 215
  • Common variable immunodeficiency due to a novel NFKB1 variant in a child with thalassemia major CVID with thalassemia major

    Kun Yang
    e2023053
    2023-08-29
    https://doi.org/10.4084/MJHID.2023.053
    729
    PDF: 569
    HTML: 170
  • Hyperhemolytic Syndrome complicating a Delayed Hemolytic Transfusion Reaction due to anti-P1 alloimmunization, in a pregnant woman with HbO-Arab?-thalassemia

    Zoe Bezirgiannidou, Anna Christoforidou, Eftychia Kontekaki, Athanasios Anastasiadis, Spyros Papamichos, Helen Menexidou, Dimitrios Margaritis, George Martinis, Elpidoforos Mandadakis
    e2016053
    2016-10-18
    https://doi.org/10.4084/mjhid.2016.053
    3218
    PDF: 914
    HTML: 1282
    Figure 1: 164
  • THE UTILITY OF BLOOD AND BONE MARROW FILMS AND TREPHINE BIOPSY SECTIONS IN THE DIAGNOSIS OF PARASITIC INFECTIONS

    Clare Miller, Barbara Bain
    e2015039
    2015-05-26
    https://doi.org/10.4084/mjhid.2015.039
    1787
    PDF: 1162
    HTML: 21424
  • SHORT TERM ADVANTAGES OF A PUBLIC-PRIVATE PARTNERSHIP FOR TUBERCULOSIS IN GUINEA BISSAU: REDUCTION OF MORTALITY AND INCREASED DIAGNOSTIC CAPACITY

    Fina Vieira, Mamadu Saliu Sanha, Fabio Riccardi, Raffaella Colombatti
    e2014049
    2014-06-29
    https://doi.org/10.4084/mjhid.2014.049
    1431
    PDF: 922
    HTML: 1283
    Untitled: 181
  • EFFECT OF CIS ACTING POTENTIAL REGULATORS IN THE ß GLOBIN GENE CLUSTER ON THE PRODUCTION OF HBF IN THALASSEMIA PATIENTS

    Anita Nadkarni
    e2013012
    2013-02-16
    https://doi.org/10.4084/mjhid.2013.012
    1154
    PDF: 605
    HTML: 3341
  • OUTCOME OF ANTIFUNGAL COMBINATION THERAPY FOR INVASIVE MOLD INFECTIONS IN HEMATOLOGICAL PATIENTS IS INDEPENDENT OF THE CHOSEN COMBINATION

    Rafael Rojas, José R. Molina, Isidro Jarque, Miguel A. Sanz
    e2012011
    2012-02-10
    https://doi.org/10.4084/mjhid.2012.011
    1133
    PDF: 550
    HTML: 1699
    Figures: 175
    Fifures Sanz: 181
    tables Sanz: 184
    Untitled: 183
  • Dose-modified lenalidomide induces sustained hematological response in patients with intermediate to high risk myelodysplasia

    Alhossain A. Khalafallah, Bernadene Fernandopulle, Terry Brain
    e2010012
    2010-05-31
    https://doi.org/10.4084/mjhid.2010.012
    1073
    PDF: 701
    HTML: 351
  • Long-term persistence of dysplastic features in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and arsenic trioxide

    Enrico Santinelli, Maria Rosaria Pascale, Luca Guarnera, Arianna Savi, Flavia Mallegni, Carmelo Gurnari, Luca Maurillo, Maria Teresa Voso, Susanna Fenu
    e2025038
    2025-04-30
    https://doi.org/10.4084/MJHID.2025.038
    1055
    PDF: 753
    HTML: 90
  • ELOTUZUMAB FOR THE TREATMENT OF RELAPSED OR REFRACTORY MULTIPLE MYELOMA, WITH SPECIAL REFERENCE TO ITS MODES OF ACTION AND SLAMF7 SIGNALING

    Masafumi Taniwaki, Mihoko Yoshida, Yosuke Matsumoto, Kazuho Shimura, Junya Kuroda, Hiroto Kaneko
    e2018014
    2018-02-15
    https://doi.org/10.4084/mjhid.2018.014
    5296
    PDF: 1948
    HTML: 1366
  • MONITORING THE RESPONSE TO TYROSINE KINASE INHIBITOR (TKI) TREATMENT IN CHRONIC MYELOID LEUKEMIA (CML)

    Ibrahim C. Haznedaroglu
    e2014009
    2013-12-31
    https://doi.org/10.4084/mjhid.2014.009
    4035
    PDF: 1535
    HTML: 9192
    Untitled: 284
    Untitled: 192
    Untitled: 176
    Untitled: 170
    Untitled: 194
    Untitled: 349
  • Successful Bridging to Allogeneic Transplantation With Valemetostat in Two Refractory/relapsed Peripheral T-cell lymphoma patients

    Gianmarco Bagnato, Vittorio Stefoni, Alessandro Broccoli, Lisa Argnani, Cinzia Pellegrini, Beatrice Casadei, Francesca Bonifazi, Pier Luigi Zinzani
    e2024004
    2024-01-01
    https://doi.org/10.4084/MJHID.2024.004
    1464
    PDF: 1416
    HTML: 194
  • Can Polycythemia Vera evolve from Acute Myeloid Leukemia? A Case Report Showing a Simultaneous Minor JAK2 V617F Mutated Clone, De novo polycythemia vera following AML remission

    Beatrice Borsellino, Arianna Savi, Maria Rosaria Pascale, Elisa Meddi, Antonio Cristiano, TIZIANA OTTONE, Maria Cristina Rapanotti, Mariadomenica Divona, SERENA TRAVAGLINI, Enrico Attardi, Elisa Buzzatti, Francesco Buccisano, Maria Teresa Voso
    e2022058
    2022-06-29
    https://doi.org/10.4084/MJHID.2022.058
    1697
    PDF: 788
    HTML: 264
  • Bortezomib maintenance for the treatment of Monoclonal Gammopathy of Renal Significance

    Holly Lee, Peter Duggan, Ernesta Paola Neri, Jason Tay, Victor Jimenez Zepeda
    e2019007
    2019-01-01
    https://doi.org/10.4084/mjhid.2019.007
    2227
    PDF: 1187
    HTML: 343
  • ASSESSMENT OF OBESITY AND HEPATIC LATE ADVERSE EFFECTS IN THE EGYPTIAN SURVIVORS OF PEDIATRIC ACUTE LYMPHOBLASTIC LEUKEMIA: SINGLE CENTER STUDY

    Farida El-Rashedy, Mahmoud Ahmed El-Hawy, Sally El Hefnawy, Mona Mohammed
    e2017026
    2017-04-15
    https://doi.org/10.4084/mjhid.2017.026
    2529
    PDF: 922
    HTML: 1302
    Untitled: 233
  • HEMATOPOIETIC CELL TRANSPLANTATION FOR OLDER PATIENTS WITH MDS

    Mazyar Shadman, Joachim Deeg
    e2014056
    2014-09-01
    https://doi.org/10.4084/mjhid.2014.056
    2048
    PDF: 774
    HTML: 3118
  • Primary Pancreatic Lymphoma in a Patient with Maturity Onset Diabetes of the Young type 3

    Valentina Bozzoli, Maria Chiara Tisi, Luigi Pianese, Stefano Tumini, Vittoria Rufini, Maria Lucia Calcagni, Dario Pitocco, Alberto Larghi, Luigi Maria Larocca, Giuseppina Massini, Luciana Teofili, Francesco D'Alò, Stefan Hohaus
    e2012005
    2012-01-18
    https://doi.org/10.4084/mjhid.2012.005
    1548
    PDF: 719
    HTML: 979
  • CLASSIC KSHV/HHV-8-POSITIVE PRIMARY EFFUSION LYMPHOMA (PEL): A SYSTEMATIC REVIEW AND META-ANALYSIS OF CASE REPORTS

    Ilaria Cozzi, Giovanni Rossi, Emma Rullo, Valeria Ascoli
    e2022020
    2022-02-27
    https://doi.org/10.4084/MJHID.2022.020
    1584
    PDF: 969
    HTML: 346
  • EPIDEMIOLOGY OF MALARIA IN THE STATE OF QATAR, 2008-2015

    Elmoubasher Farag, Devendra Bansal, Mohamad Abdul Halim Chehab, Ayman Al-Dahshan, Mohamed Bala, Nandakumar Ganesan, Yosuf Abdulla Al Abdulla, Mohammed Al Thani, Ali H. Sultan, Hamad Al-Romaihi
    e2018050
    2018-09-01
    https://doi.org/10.4084/mjhid.2018.050
    1993
    PDF: 1012
    HTML: 432
  • How we manage invasive fungal disease in acute myeloid leukemia patients with Glucose 6 Dehydrogenase deficiency

    Marco Sanna, Giovanni Caocci, Giorgio La Nasa
    e2017047
    2017-08-14
    https://doi.org/10.4084/mjhid.2017.047
    1851
    PDF: 925
    HTML: 970
    Referring article: 754
  • DISSEMINATED HISTOPLASMOSIS IN IMMUNOCOMPETENT INDIVIDUALS- NOT A SO RARE ENTITY

    Dibyendu De, Uttam Kumar Nath
    e2015028
    2015-04-19
    https://doi.org/10.4084/mjhid.2015.028
    2426
    PDF: 1112
    HTML: 2173
    Untitled: 169
  • REGULATORY T-CELLS IN CHRONIC LYMPHOCYTIC LEUKEMIA

    Giovanni D'arena, Giovanni Rossi, Barbara Vannata, Silvia Deaglio
    e2012053
    2012-08-09
    https://doi.org/10.4084/mjhid.2012.053
    2353
    PDF: 1005
    HTML: 7629
    Untitled: 287
    Fig2: 189
    Fig3: 178
    Fig4: 187
  • Successful Treatment with Imipenem/Cilastatin/Relebactam of a Polymicrobial Bacteremia due to Meropenem/Vaborbactam-Resistant KPC-Producing Klebsiella pneumoniae and Enterococcus faecalis

    Federico Marzi, Mario Alessandri, Veronica De Crescenzo, Stefania Del Vecchio, Simone Radi, Maurizio Manini
    e2026037
    2026-04-30
    https://doi.org/10.4084/MJHID.2026.037
    258
    HTML: 93
    PDF: 117
  • CAR-T CELL THERAPY IN B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA CAR-T CELL and B-ALL

    Ugo Testa, Prof. Sica, Dr. Pelosi, Dr. Germana Castelli, Prof. Leone
    e2024010
    2024-01-01
    https://doi.org/10.4084/MJHID.2024.010
    4359
    PDF: 3578
    HTML: 221
  • Successful treatment of gastric relapse in multiple myeloma with bortezomib after autologous hematopoietic stem cell transplantation (autoHSCT)

    Serdar Sivgin
    e2013006
    2013-01-02
    https://doi.org/10.4084/mjhid.2013.006
    1166
    PDF: 638
    HTML: 3251
  • ATRA induced Reactive Hemophagocytosis: A Case Report

    Monica Sharma, Sanjeev Kumar Sharma, Jasmita Dass, Seema Tyagi
    e2011034
    2011-09-08
    https://doi.org/10.4084/mjhid.2011.034
    1248
    PDF: 606
    HTML: 2870
    ATRA induced Reactive Hemophagocytosis: A Case Report: 203
  • CLASSICAL HODGKIN LYMPHOMA TODAY

    Francesco D'Alò, Gabriele Schiaffini, Daniele Mazzoni, Eleonora Alma, Flaminia Bellisario, Marcello Viscovo, Elena Maiolo, Silvia Bellesi, Stefan Hohaus
    2026-06-30
    https://doi.org/10.4084/MJHID.2026.055
    337
    PDF: 190
    HTML: 38
  • Guest Editor: Pellegrino Musto HOW FIRST-LINE THERAPY IS CHANGING IN NON-TRANSPLANT ELIGIBLE MULTIPLE MYELOMA PATIENTS.

    Daniele Derudas
    e2025025
    2025-02-27
    https://doi.org/10.4084/MJHID.2025.025
    1571
    PDF: 1391
    HTML: 117
  • The THE PLASMABLASTIC LYMPHOMA. A STATE-OF-THE-ART REVIEW: PART 2-FOCUS ON THERAPY

    Michele Bibas
    e2024015
    2024-02-29
    https://doi.org/10.4084/MJHID.2024.015
    1817
    PDF: 1691
    HTML: 898
  • SYSTEMIC MASTOCYTOSIS: MULTIDISCIPLINARY APPROACH Systemic Mastocytosis

    Roberta Zanotti, Massimiliano Bonifacio, Ilaria Tanasi, Donatella Schena, Giovanni Orsolini, Morena Tebaldi, Lara Crosera, Francesca Mastropaolo, Elisa Olivieri, Dr. Patrizia Bonadonna
    e2021068
    2021-10-29
    https://doi.org/10.4084/MJHID.2021.068
    1588
    PDF: 1046
    HTML: 238
  • ASSOCIATION OF VDBP RS4701 VARIANT, BUT NOT VDR/RXR-? OVER-EXPRESSION WITH BONE MINERAL DENSITY IN PEDIATRIC ?-THALASSEMIA PATIENTS Vitamin D metabolic axis and BMD in ?-thalassemia

    Shaimaa Sahmoud, Mostafa S. Ibrahim, Eman A. Toraih, Noha Kamel, Manal Fawzy, Samar Elfiky
    e2020037
    2020-06-28
    https://doi.org/10.4084/mjhid.2020.037
    1278
    PDF: 740
    HTML: 212
  • LIVER IRON CONTENT (LIC) IN ADULTS WITH NON-TRANSFUSION DEPENDENT SICKLE CELL DISEASE (NT-SCD). CORRELATION WITH SERUM FERRITIN AND LIVER ENZYMES CONCENTRATIONS

    Vincenzo De Sanctis
    e2017037
    2017-06-20
    https://doi.org/10.4084/mjhid.2017.037
    3949
    PDF: 991
    HTML: 1154
  • CURRENT ROLE OF AUTOLOGOUS AND ALLOGENEIC STEM CELL TRANSPLANTATION FOR RELAPSED AND REFRACTORY HODGKIN LYMPHOMA

    Luca Castagna, Carmelo Carlo-Stella, Rita Mazza, Armando Santoro
    e2015015
    2015-02-12
    https://doi.org/10.4084/mjhid.2015.015
    2817
    PDF: 1428
    HTML: 4630
  • Multiple Myeloma and Paget’s disease with abnormal skull lesions and intracranial hypertension

    Tommaso Caravita, Agostina Siniscalchi
    e2112068
    2012-11-04
    https://doi.org/10.4084/mjhid.2012.068
    1116
    PDF: 671
    HTML: 10844
351 - 400 of 446 items << < 3 4 5 6 7 8 9 > >> 
Make a Submission

Links

  • Editorial Board
  • Alert me!
  • Advertising
  • Scopus
  • DOAJ
  • Article Processing Charge

Information

  • For Readers
  • For Authors
  • For Librarians

Indexing

  • OpenAlex
  • Analytics

PubMed

MJHID CiteScore by Scopus

Clarivate Analytics

this journal is covered
by Clarivate Analytics

 

The Mediterranean Journal of Hematology and Infectious Diseases has been selected for coverage in Clarivate Analytics products and services. Beginning with V. 7 (1) 2015.

AskBisht

Indexed in AskBisht.com

Facebook

FOLLOW US

MJHID in EuroPub Database

EuroPub

CLL UpDate

Keywords

Mediterranean Journal of Hematology and Infectious Diseases

is owned by the U.C.S.C. and it is published by PAGEPress®, Pavia, Italy. The MJHID is indexed and abstracted in Science Citation Index Expanded and Journal Citation Reports/InCites beginning with V. 7 (1) 2015.

eISSN: 2035-3006

Info

  • About
  • Editorial Board
  • News
  • Advertising

Info Submission

  • Submission

Our App Is Free For Anyone!

© PAGEPress 2008-2026    •    PAGEPress® is a registered trademark property of PAGEPress srl, Italy    •    VAT: IT02125780185
This journal is published by PAGEPress® srl (Pavia, Italy), which is the data controller for all personal data processed through this platform. For full details on how your data is collected, used and protected, please read our Privacy Policy.